Transcelerate Biopharma Inc., a nonprofit established by 10 of the industry's largest pharmas in 2012 – and has doubled its membership since then – is charged with the task of reducing redundancy and speeding drug development for its member drug companies. (See BioWorld Today, Sept. 26, 2012.)